Your browser doesn't support javascript.
loading
Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.
He, Qiushan; Li, Jinlong; Yin, Weihua; Song, Zhichun; Zhang, Zhen; Yi, Tienan; Tang, Jia; Wu, Demin; Lu, Yue; Wang, Zhen; Liu, Dan; Zhang, Xiaoren; Hu, Zhiming; Gao, Jimin.
Affiliation
  • He Q; Zhejiang Provincial Key Lab for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical College, University Park, Wenzhou, China.
Cancer Immunol Immunother ; 60(5): 715-30, 2011 May.
Article in En | MEDLINE | ID: mdl-21331814

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Granulocyte-Macrophage Colony-Stimulating Factor / Paclitaxel / Cancer Vaccines / Antineoplastic Agents, Phytogenic Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2011 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Granulocyte-Macrophage Colony-Stimulating Factor / Paclitaxel / Cancer Vaccines / Antineoplastic Agents, Phytogenic Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2011 Type: Article Affiliation country: China